RN Collins (Series 3) No.9: Psychedelic Licensing Equity: What Cannabis’s Experience May Predict

RN Collins, M.S., JD Candidate https://www.linkedin.com/in/rn-collins/

I. Introduction

When Oregon began accepting applications for psilocybin service center licenses on January 2, 2023, advocates were watching one metric above all others: who was getting licenses. The cannabis industry had been here before. Licensing processes nominally designed to prioritize communities harmed by prohibition had, in state after state, produced licensing regimes that appear to have generated paperwork equity while leaving the underlying capital, capacity, and structural access gaps largely untouched.

Illinois granted 244 dispensary licenses, of which 134 are social equity licenses. As of early 2026, approximately 64% of those equity licenses appear to be operational, a figure suggesting a substantial gap between licensure and operation remains even under one of the more developed state equity frameworks. Oregon’s psilocybin equity program has no legislative funding allocated for 2025-27. Colorado’s social equity framework is still being designed for a market that opened in spring 2025. The cannabis industry’s experience over roughly five years may indicate that equity licenses without accompanying equity capital risk becoming largely symbolic. The psychedelic industry appears to be encountering a similar pattern more quickly, and adds a dimension that cannabis regulation never squarely addressed: the position of indigenous communities whose traditional plant knowledge underlies much of the commercial value now being licensed, with those communities generally offered, at most, marginal formal access to the resulting industry.

This article maps the equity question in three layers. Section II reviews the cannabis social equity record and considers which specific failure modes the Oregon and Colorado frameworks do and do not appear to address. Section III examines the Oregon and Colorado equity architectures in some detail, including a possible dormant Commerce Clause vulnerability suggested by Variscite NY Four. Section IV discusses the indigenous dimension, a psychedelic-specific equity question that the cannabis framework never squarely confronted. Section V sets out considerations that a more effective equity framework might need to incorporate, framed as recommendations for regulators and legislators. Section VI closes with observations on how these questions may intersect with existing legal frameworks going forward.

II. The Cannabis Social Equity Record

A. A Pattern That May Reflect Structural Difficulty

The cannabis social equity record across roughly eleven years of state-level legalization suggests a recurring pattern: equity licensing programs appear to produce equity license applications more reliably than they produce equity licensees actually in operation. The gap between license grant and operational business is where these programs seem most likely to fall short, and the shortfall looks structural rather than incidental, though the evidence supporting that inference is necessarily program-specific and may not generalize cleanly across states.

Illinois’ Cannabis Regulation and Tax Act (CRTA), 410 ILCS 705/1 et seq., created what may be the most comprehensive social equity licensing framework among the states that have legalized adult-use cannabis. The CRTA defines social equity applicants by reference to areas disproportionately impacted (ADI) by cannabis enforcement, residence history, and prior cannabis conviction history. It created a priority licensing tier, a low-interest loan program, technical assistance, and fee waivers. Of the 134 social equity dispensary licenses issued, approximately 64% are operational as of 2026, according to Illinois Department of Financial and Professional Regulation reporting. The non-operational licenses represent applicants who received the state’s recognition of equity status but were apparently unable to secure the capital, real estate, and operational infrastructure needed to open.

The pattern does not appear to be limited to Illinois. Massachusetts, California, and Michigan each produced equity licensing frameworks that seem to have generated substantially more equity applications than equity businesses actually operating. One plausible common factor is capital access: social equity applicants may often lack access to the private capital markets that non-equity applicants can draw on for facility acquisition, inventory, and operating costs during the pre-revenue period. This is an inference from the pattern rather than a claim that has been independently verified against underlying financing data for each program.

B. A Possible Dormant Commerce Clause Problem: Variscite NY Four

A constitutional vulnerability in residency-based equity preferences was confirmed, at least in the cannabis context, by Variscite NY Four, LLC v. New York State Cannabis Control Board, No. 24-384 (2d Cir. Aug. 12, 2025). The case addressed New York’s Conditional Adult Use Retail Dispensary (CAURD) program, and specifically an “Extra Priority” rule that advantaged applicants (or their relatives) who sustained New York-specific cannabis convictions. The Second Circuit held that this rule facially discriminates against out-of-state economic interests under the dormant Commerce Clause, reasoning that New York convictions function as a residency proxy and that New York had not shown the measure was the only way to advance its restorative-justice goals.

This holding may be relevant to psychedelic equity preferences that incorporate residency requirements or state-specific business history as a condition of equity eligibility. Oregon’s OAR 333-333-1090 equity eligibility criteria include residence in a disproportionately impacted area, an Oregon-specific geographic qualification. Colorado’s equity framework similarly incorporates state-specific residence history. To the extent these criteria condition equity benefits on in-state residence or business history, they may raise a dormant Commerce Clause question comparable to the one Variscite identified in the CAURD context, though the fact-specific nature of dormant Commerce Clause analysis and the differences between the cannabis and psychedelic regulatory contexts mean this inference cannot be stated with the same confidence the Variscite court applied to CAURD specifically.

State regulators administering psychedelic equity programs may wish to review residency-based eligibility criteria for possible constitutional exposure and consider modeling alternative eligibility metrics, disproportionate enforcement impact, conviction history, neighborhood economic indicators, that could achieve similar equity objectives without relying as heavily on in-state residence or business history.

III. The Psychedelic Equity Architecture: Oregon and Colorado

A. Oregon: OAR 333-333-1090

Oregon’s equity program under OAR 333-333-1090 defines psilocybin equity service centers and facilitators by reference to criteria including: residence in a disproportionately impacted area for at least two of the five years preceding the application; income at or below 400% of the federal poverty level; past cannabis conviction; or membership in a household with a person with a past cannabis conviction. The program provides technical assistance through a partnership with the Secretary of State’s Office of Small Business Assistance, fee reductions, and priority application processing.

A funding gap may compound the limitations of this design: OHA reportedly drew $3.1 million from Oregon’s general fund to operate the program during the 2023-25 biennium, and the Legislature appears to have allocated no program funding for 2025-27. OHA has indicated that licensing fees may increase. For equity applicants operating on thin margins, a fee increase could represent a meaningful operational pressure. Legislators considering the program’s future funding structure may wish to treat this gap as a priority item, since the technical assistance and fee-reduction provisions depend on continued appropriations that are not currently secured.

An additional market-reality consideration for equity program analysis: as of January 2026, approximately one-third of Oregon’s licensed service centers appear to have closed. The equity applicants that the OAR 333-333-1090 program is designed to serve, operators from disproportionately impacted communities with comparatively limited access to private capital, may be more vulnerable to the market conditions that appear to have driven closures in the first operator cohort. Program designers and capital-access analysts may want to model not only startup costs but sustained operating costs over the period likely required to reach cash-flow stability, particularly in a market that has already shown signs that operating cost pressure can be a significant failure mode.

B. Colorado: The Developing Framework

Colorado’s Natural Medicine Health Act created a social equity framework under DORA’s 4 CCR 755-1, with equity criteria including residence in a disproportionately impacted area, income below 200% of the federal poverty level, and prior drug conviction history. Unlike Oregon’s program, which launched with cannabis-informed equity criteria already in view, Colorado’s framework launched before the market was fully operational, which may have given equity designers an opportunity to avoid some of the failure modes documented in the cannabis record. Whether that opportunity has in fact been taken appears to depend largely on whether the capital access problem, rather than the licensing access problem alone, has been meaningfully addressed, a question this article cannot resolve conclusively on the present record.

C. What Neither Framework Appears to Have Addressed

Neither Oregon’s nor Colorado’s equity framework appears to squarely address the level of professional application support that psychedelic service center licensing may require. The OHA technical assistance program provides access to the Secretary of State’s Small Business Assistance program, which is designed for general small business formation and may not be well suited to the entity formation, OAR-compliant operating plan development, background investigation preparation, and facilitator training program verification that psychedelic service center licensing appears to demand. Professional legal and compliance assistance at the application stage looks like a gap that a more effective equity support program would need to fill.

Application support programs might usefully cover three categories that the current OHA technical assistance program does not appear to reach. First, legal compliance assistance: entity formation, background investigation preparation, OAR-compliant operating plan development, and facilitator training program verification each seem to require professional legal or compliance expertise that general small-business programs are not designed to provide. Second, facility planning: OHA’s session environment requirements and security mandates appear to require architectural and construction planning that equity applicants without prior commercial real estate experience may struggle to perform without professional assistance. Third, ongoing regulatory navigation: equity licensees who make it through the application process still appear to need compliance support through OHA inspections, SB 303 reporting, and license renewal. A well-designed program might deliver these services through a contracted professional services provider accountable to the licensing agency, rather than through informational workshops that may presuppose a level of professional capacity the applicant does not yet have.

IV. The Indigenous Dimension: A Psychedelic-Specific Equity Question

A. What Cannabis Frameworks Never Squarely Confronted

Cannabis social equity frameworks are premised on a specific historical claim: that over-enforcement of cannabis prohibition in communities of color produced arrest records, felony convictions, and economic exclusion that disadvantaged those communities relative to the predominantly white and comparatively wealthy operators who entered the legal market. The equity claim is retrospective, addressing a harm the regulatory system is understood to have helped inflict.

Psychedelic equity appears to share this dimension, psilocybin enforcement seems to have been applied disproportionately in some communities, and the communities most affected by prohibition are, at present, generally being offered only marginal formal access to the market their prosecution may have helped create. But psychedelic equity also raises a second dimension that cannabis regulation never squarely confronted: the use of indigenous traditional knowledge as a commercial foundation. The commercial psychedelic industry draws substantially on the sacred plant traditions of Mazatec, Shipibo, Huichol, and other indigenous communities whose ceremonial use of psilocybin, ayahuasca, peyote, and related plants appears to underlie much of the knowledge base for the therapeutic model now being commercialized. No state psychedelic framework currently appears to require any form of benefit-sharing with these communities, and no state equity program appears to identify them as a target population, though this article does not purport to have surveyed every state or municipal framework, and the absence of such a requirement should not be read as a complete inventory.

B. The Legal Framework That May Apply, and Its Apparent Limits

The federal Indian law framework, the American Indian Religious Freedom Act (AIRFA), 42 U.S.C. § 1996; its 1994 Amendments, 42 U.S.C. § 1996a; and the Religious Freedom Restoration Act, 42 U.S.C. § 2000bb et seq., appears to provide partial protection for indigenous ceremonial use, but does not appear to create affirmative benefit-sharing obligations for commercial operators. The AIRFA Amendments protect peyote use by members of the Native American Church for bona fide traditional ceremonial purposes, a protection that Oregon and Colorado appear to have honored by excluding peyote from their service center frameworks. RFRA provides a compelling-interest defense against government prohibition of specific religious use, as illustrated in Gonzales v. O Centro Espirita Beneficente Uniao do Vegetal, 546 U.S. 418 (2006). Neither framework, as far as this analysis can determine, requires commercial operators to acknowledge, credit, or compensate indigenous knowledge sources.

The Nagoya Protocol on Access and Benefit Sharing, adopted October 29, 2010 and in force as of October 12, 2014, requires parties to work to ensure that benefits from the utilization of genetic resources and associated traditional knowledge are shared equitably with provider communities. The United States has not ratified the Nagoya Protocol, it appears to be the only UN member state that has not ratified the Convention on Biological Diversity, and is therefore likely not bound by the Protocol’s obligations as a matter of domestic law. That said, as of August 2025, 142 parties have reportedly ratified the Protocol, and US commercial operators seeking European pharmaceutical partnerships, EU investment, or EU market access may face compliance expectations imposed contractually by European counterparts even in the absence of a US domestic obligation. This is a contractual and commercial-pressure point rather than a legal mandate, and its practical force likely varies by counterparty and transaction.

One of the more concretely actionable legal tools in this area may be the AIA’s prior art doctrine. Under 35 U.S.C. § 102(a)(1), as amended by the Leahy-Smith America Invents Act (Pub. L. 112-29, Sept. 16, 2011), a claimed invention is generally not patentable if it was “otherwise available to the public” before the effective filing date. The AIA’s elimination of the pre-AIA geographic limitation suggests that traditional indigenous knowledge documented in the ethnobotanical literature, including R. Gordon Wasson’s 1957 Life magazine account of Mazatec psilocybin ceremonies, could constitute prior art against at least some psychedelic patent claims covering that knowledge, though whether any particular claim would be invalidated depends heavily on the specific claim language and would need case-by-case analysis. A traditional knowledge prior art search appears to be a prudent step in psychedelic patent strategy generally, though this article does not offer that as a categorical rule applicable to every filing. Students for Fair Admissions v. Harvard, 600 U.S. 181 (2023), is noted here as a possible constitutional constraint on race-conscious equity program design; its application to the indigenous benefit-sharing context is a separate question that this article does not attempt to resolve.

C. Tools Available in the Absence of a Statutory Mandate

In the absence of a statutory benefit-sharing requirement, several tools appear to be available to commercial operators and their advisors, though none functions as a substitute for a legislative or regulatory mandate. First, voluntary benefit-sharing agreements: a formal arrangement specifying the genetic resources covered, the benefit calculation mechanism, the payment schedule, the audit right, and the dispute resolution mechanism could create an enforceable contractual obligation even without a statutory mandate, assuming such an agreement is negotiated and executed in the first place. Second, FTC exposure: a psychedelic company that publicly represents itself as indigenous-partnership-committed without documented benefit-sharing arrangements may be making an unsubstantiated social claim that could be actionable under 15 U.S.C. § 45 and the FTC’s Green Guides framework, though enforcement in this specific area does not yet appear to have a developed track record. Third, prior art clearance: a traditional knowledge prior art search appears to be a reasonable component of freedom-to-operate analysis for companies pursuing patent protection in this space.

V. Recommendations for Regulators and Legislators

The cannabis equity record and the psychedelic framework analysis together suggest three areas that state regulators and legislators may wish to address in designing or revising equity programs. Each corresponds to a failure mode that appears, at least tentatively, in the cannabis record.

V.A State Regulators Should Consider Building Capital Access Into Licensing Programs, Not Just License Priority

Equity licenses without accompanying equity capital appear likely to produce equity applicants who are unable to open. State regulators and legislators may wish to consider pairing priority licensing with direct capital mechanisms, grants, low-interest loans, or royalty-based financing. The Illinois Restore, Reinvest, and Renew (R3) program, which directs cannabis tax revenue to communities disproportionately impacted by drug enforcement, may offer one model worth examining further. Oregon’s equity program does not currently appear to provide direct capital; Colorado’s framework does not yet appear to have an operational capital access mechanism. Absent such a mechanism, it seems unlikely that either framework fully addresses what may be the most common failure mode identified in the cannabis experience.

V.B Licensing Agencies May Wish to Fund Substantive, Professional-Level Application Support

Psychedelic service center applications appear to require professional legal, compliance, and facility planning assistance that general informational workshops may not adequately provide. Licensing agencies could consider funding these services through license fee set-asides and delivering them through contracted professional services providers accountable to the agency. The current OHA partnership with the Secretary of State’s Small Business Assistance program appears to address general small business formation but not the more specific legal and compliance demands of psychedelic service center licensing.

V.C Regulators May Wish to Build in Ongoing Regulatory Navigation Support, Not Just One-Time Application Assistance

Equity licensees who make it past the application stage still appear to need sustained compliance support: OHA inspections, SB 303 reporting, license renewal, insurance gap management, and the evolving standard-of-care obligations that early facilitator negligence cases may help establish over time. A one-time application assistance program does not appear to address this ongoing need. State agencies designing equity frameworks may wish to build a regulatory navigation function into the program from the outset, whether through an equity ombudsperson, a subsidized legal services program, or a dedicated compliance assistance line, rather than treating equity support as a front-loaded, one-time intervention.

VI. Concluding Observations

On the operator side, this analysis suggests that equity status may affect not only licensing priority but also fee obligations, technical assistance access, and, if a capital access component develops, financing availability. Anyone navigating a psychedelic service center application process may find it useful to understand the eligibility criteria in detail and to monitor the relevant program’s funding status, since the support obligations attached to equity status may or may not be operational by the time an applicant needs them.

On the advocacy side, the three structural gaps discussed above, capital access, professional application support, and ongoing regulatory navigation, appear to be the priority items that program design conversations with state licensing agencies or legislative staff might reasonably focus on. An equity program that addresses licensing access alone risks replicating what the cannabis record suggests was an incomplete approach. The cannabis equity experience may serve as useful evidentiary support for advocacy toward programs that address all three gaps from the outset, though this article does not claim that record proves any particular design choice will succeed in the psychedelic context.

On the indigenous rights question, a traditional knowledge prior art search, a voluntary benefit-sharing framework assessment, and an FTC social claim review appear to be reasonable components for commercial psychedelic ventures to consider building into their early planning. These are not offered here as legal requirements, but as risk-management considerations that may become more salient as ESG investor standards, European partnership requirements, and FTC enforcement attention continue to evolve around traditional knowledge-related social claims.

Endnotes